A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
about
Antioxidant supplements for preventing gastrointestinal cancersAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAntioxidant supplements for preventing gastrointestinal cancersShort term changes in lung function, leukocytosis in blood, and lachrymal fluid among bacterial single cell protein workers after an episode with high exposure to endotoxins.A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo.Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trialAccelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction.Combined oral contraceptives and the risk of myocardial infarction.Fibrinogen--marker or mediator of vascular disease?The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseasesThe role of hemorheological factors in cardiovascular medicineThe role of intima-media-thickness, ankle-brachial-index and inflammatory biochemical parameters for stroke risk prediction: a systematic review.Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.Pleiotropic effects of niacin: Current possibilities for its clinical use.Comparison of hemorheological changes in patients after acute coronary events, intervention and ambulatory rehabilitation.Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.Structural effects of methionine oxidation on isolated subdomains of human fibrin D and αC regions.Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease.Evaluation of fluid warmer safety using hemorheologic analysis with outdated human blood.Detailed evaluation of a newly attained fungal pigment from Monascus purpureus in meat burgers.Human cardiomyocyte interaction with electrospun fibrinogen/gelatin nanofibers for myocardial regeneration.The relationship between attendance at religious services and cardiovascular inflammatory markers.
P2860
Q24242191-DA1D2D5A-FAC1-4656-805B-FEF01436F29CQ24242944-237D827F-94D3-40B5-A85A-0522DB0214F4Q24245704-9AB8BDE0-38F2-4A33-979D-022912D65DD0Q33220405-35F8FC99-DE2E-4FCC-BE34-15DD0D7CF04EQ33633625-A2A8B1C1-1404-478F-95C1-54B35357CAC9Q34248508-B93EAB58-4A99-40BF-B7BB-DE112EB79398Q34601733-01405CB9-9388-4FFC-9850-AC0907188AA4Q34973446-C55AC9E1-7DB9-4664-9A59-CE2D7F1961D7Q35544330-9D797526-D177-4DD0-885C-23890E440B7BQ35565498-A811ADCB-2286-445C-8AB6-0EBB61B57C9FQ35677944-50885D53-3698-4ED9-9A1E-D2B062B0EED3Q35738921-2873281E-3617-4721-BAE4-2FE459067420Q37082872-5DCC0599-2CEA-4835-A892-C94B3451B4FFQ37927179-16B97D7D-B87A-4C70-AA60-20E210A234FCQ38546311-20EA1D5B-F3DA-40F0-B58F-6A5D32B740A4Q38810790-F4AA86FD-3D8B-4306-A6F4-72AA27A0B870Q39239230-7A4120B6-BCAB-4997-A588-8BFBFA5904AEQ40301622-0E150472-ED6B-486F-AAD6-AC4A3EF56120Q41894087-643D5714-3577-4B5C-B67F-FDDEA95DD9AFQ42137305-D923E3A2-862F-49A6-B948-16A9DB8385EFQ44877647-026B98F5-7D00-4AA5-8F6E-5F31DCCC4C71Q45060767-BCB8BCC1-3839-44AD-BBF2-AF7F8AEE8E45Q47654650-EA1C22B2-CAAB-4CB1-9110-F48235F2A809Q50452772-00A55BAE-0CBD-4FA6-8FCE-41A4726510C9Q50515751-612686EB-8978-4ACD-96EE-632663311E49Q51049444-2FFFB75B-8612-404F-949B-E7F9E2225D2CQ53441808-8D60D594-1673-4E36-8A44-46AFC2F4E4BE
P2860
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A prospective study of fibrino ...... the Physicians' Health Study.
@en
type
label
A prospective study of fibrino ...... the Physicians' Health Study.
@en
prefLabel
A prospective study of fibrino ...... the Physicians' Health Study.
@en
P2093
P1476
A prospective study of fibrino ...... the Physicians' Health Study.
@en
P2093
P304
P356
10.1016/S0735-1097(99)00007-8
P407
P577
1999-04-01T00:00:00Z